GlassScriptPhysician profile
Robyn Santiago
NPI 1992143465
$6,633.92
in general payments reported to CMS, 2019-2025
33 companies · $1,402 in 2025
The $1,402 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $385 · 2022: $1,732 · 2023: $1,797 · 2024: $1,318 · 2025: $1,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,458 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,457.70 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,324.16 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $903.87 | 2021-2025 | |
| Glaxosmithkline, LLC. | $842.14 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $421.25 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $406.43 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $389.70 | 2021-2025 | |
| Astellas Pharma US INC | $267.92 | 2024-2025 | Veozah |
| Amgen INC. | $216.75 | 2023-2025 | Repatha, Otezla, Otezla |
| Currax Pharmaceuticals LLC | $199.75 | 2021-2024 | Contrave, Onzetra Xsail |
| Exact Sciences Corporation | $160.13 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $140.91 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $138.19 | 2021-2023 | |
| Esperion Therapeutics, INC. | $136.55 | 2022-2025 | Nexletol |
| Idorsia Pharmaceuticals US INC | $125.14 | 2023-2024 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $120.01 | 2024-2025 | Zoryve |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $89.28 | 2022-2025 | Freestyle Libre 3, Jot Dx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.85 | 2023-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $71.66 | 2022 | |
| Dexcom, INC. | $69.23 | 2021-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $62.71 | 2021-2022 | |
| Phadia US INC. | $61.66 | 2023-2024 | Immunocap |
| Bausch Health US, LLC | $60.84 | 2022-2023 | Aplenzin |
| Janssen Pharmaceuticals, INC | $60.33 | 2022-2023 | Xarelto, Spravato |
| Paratek Pharmaceuticals, INC. | $52.80 | 2023-2025 | Nuzyra, Xhance |
| Hologic Sales and Service, LLC | $43.41 | 2022-2023 | Thinprep 2000 Processor, Aptima |
| Verity Pharmaceuticals INC. | $35.68 | 2024-2025 | Tlando |
| Merck Sharp & Dohme LLC | $32.70 | 2022-2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Phathom Pharmaceuticals, INC. | $26.68 | 2024 | Voquezna |
| Ironshore Pharmaceuticals INC. | $21.94 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.50 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.32 | 2022 | |
| Tolmar, INC. | $14.72 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Santiago listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.